Clinical Trials in San Antonio

Showing 4921-4940 of 11,125 trials

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

NCT04785638

This is a multicenter, Phase 3, open-label, safety, tolerability, and characterization of pharmacokinetics study of the INL 001 (bupivacaine HCl) implant, at 300 mg, in patients following various soft-tissue surgeries: open ventral hernia repair, abdominoplasty, open abdominal hysterectomy, laparoscopic-assisted colectomy, and reduction mammoplasty.

Pain, PostoperativeHernia, VentralAbdominoplasty+3 more

Innocoll100 participantsStarted Apr 2021

Florence, Alabama, United States • Sheffield, Alabama, United States • Pasadena, California, United States +5 more locations

COMPLETEDPhase 1< 1 mile

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

NCT01023737

This study is an open label non randomized study of hydroxychloroquine (HCQ) with histone deacetylase (HDAC) inhibitor Vorinostat in patients with advanced solid tumors to determine the maximum tolerated dose (MTD) and to evaluate the safety and antitumor activity of this drug combination.

Malignant Solid Tumour

The University of Texas Health Science Center at San Antonio72 participantsStarted Nov 2009

San Antonio, Texas, United States

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

Find Trials by Condition in San Antonio

Clostridium Difficile Vaccine Efficacy Trial

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

Web-based Implementation for the Science of Enhancing Resilience Study

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

Validation of a Salivary miRNA Diagnostic Test for ASD

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection